Luye Pharma Group Ltd. (HKG: 2186)

Luye Pharma Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,340	3,239	2,324	2,438	3,865	2,327
Short-Term Investments	1,509	1,272	1,247	387.86	109	1,001
Trading Asset Securities	1,631	1,596	1,974	2,684	1,432	551.74
Cash & Short-Term Investments	6,480	6,106	5,544	5,510	5,406	3,880
Cash Growth	-18.05%	10.14%	0.62%	1.92%	39.33%	10.78%
Accounts Receivable	2,578	2,355	1,784	1,765	1,553	1,813
Other Receivables	-	320.52	550.76	668.41	253.52	128.58
Receivables	2,578	2,675	2,334	2,434	1,807	1,942
Inventory	815.55	827.86	772.94	746.34	612.3	617.18
Prepaid Expenses	-	94.13	466.54	-	93.7	49.62
Restricted Cash	-	-	32	31.98	37.47	36.64
Other Current Assets	2,663	999.44	1,636	1,675	2,014	2,997
Total Current Assets	12,536	10,703	10,786	10,397	9,970	9,522
Property, Plant & Equipment	5,259	5,089	4,589	4,203	4,016	3,533
Long-Term Investments	1,574	1,968	1,114	582.2	71.46	71.87
Goodwill	1,024	1,042	1,003	985.41	1,057	1,038
Other Intangible Assets	6,503	4,805	4,448	4,080	3,765	4,102
Long-Term Deferred Tax Assets	235.4	144.59	113.95	133.11	114.74	93.86
Long-Term Deferred Charges	-	1,513	1,536	1,362	1,005	583.75
Other Long-Term Assets	66.69	226.1	658.43	839.37	631.68	464.14
Total Assets	27,198	25,491	24,250	22,582	20,631	19,408
Accounts Payable	797.01	767.19	559.94	570.89	485.26	341.05
Accrued Expenses	-	746.77	686.18	430.41	210.47	344.65
Short-Term Debt	5,456	4,568	4,723	4,740	5,415	3,806
Current Portion of Long-Term Debt	1,196	609.05	2,102	500.62	214.81	218.69
Current Portion of Leases	17.95	18.5	15.25	22.75	13.01	16.63
Current Income Taxes Payable	329.79	200.33	133.2	141.14	308.35	203.8
Current Unearned Revenue	29.42	156.55	72.83	70.99	131.19	66.9
Other Current Liabilities	1,949	1,071	1,195	853.54	455.97	704.62
Total Current Liabilities	9,774	8,138	9,487	7,330	7,234	5,703
Long-Term Debt	2,734	3,176	2,241	4,208	4,327	4,498
Long-Term Leases	50.09	52.15	23.24	19.21	11.73	12.33
Long-Term Unearned Revenue	101.31	172.22	384.44	209.39	185.66	133.05
Long-Term Deferred Tax Liabilities	38.68	47.26	56.03	57.87	74.32	77.77
Other Long-Term Liabilities	411.35	372.65	1,013	1,636	690.76	55.81
Total Liabilities	13,114	11,962	13,208	13,468	12,532	10,487
Common Stock	486.11	486.11	456.95	455.84	417.99	420.57
Additional Paid-In Capital	4,250	4,159	3,077	1,716	1,042	2,699
Retained Earnings	-	7,381	6,667	6,062	6,209	5,688
Treasury Stock	-	-	-279.56	-279.56	-279.56	-279.56
Comprensive Income & Other	8,283	505.21	254.46	534.04	501.52	381.88
Total Common Equity	13,019	12,531	10,176	8,488	7,891	8,910
Minority Interest	1,065	997.31	865.77	625.78	207.78	10.05
Shareholders' Equity	14,085	13,528	11,042	9,114	8,099	8,920
Total Liabilities & Equity	27,198	25,491	24,250	22,582	20,631	19,408
Total Debt	9,453	8,424	9,105	9,491	9,982	8,552
Net Cash (Debt)	-2,973	-2,318	-3,560	-3,980	-4,575	-4,672
Net Cash Per Share	-0.79	-0.62	-1.02	-1.16	-1.43	-1.45
Filing Date Shares Outstanding	3,762	3,762	3,550	3,541	3,183	3,203
Total Common Shares Outstanding	3,762	3,762	3,550	3,541	3,183	3,203
Working Capital	2,761	2,565	1,299	3,066	2,736	3,819
Book Value Per Share	3.46	3.33	2.87	2.40	2.48	2.78
Tangible Book Value	5,492	6,684	4,724	3,423	3,070	3,771
Tangible Book Value Per Share	1.46	1.78	1.33	0.97	0.96	1.18
Buildings	-	2,013	1,707	1,602	1,455	1,230
Machinery	-	3,636	3,408	3,031	2,718	2,490
Construction In Progress	-	1,381	1,081	832.93	864.86	653.75
Leasehold Improvements	-	54.98	43.93	40.26	25.4	23.85

Source: S&P Capital IQ. Standard template. Financial Sources.